ArticleFrontiers in immunology2025
Integrating deep learning features from mammography with SHAP values for a machine learning model predicting over 5-year recurrence of breast ductal carcinoma
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Simultaneous Preoperative Prediction of Locally Advanced Breast Cancer, DCIS Component, and Multifocality Using Structured Mammographic Features and Gradient-Boosting Machine Learning.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- Interpretable machine learning distinguishes skip from continuous metastasis in N1b papillary thyroid carcinoma.Scientific reports · 2026Article
- A weakly supervised deep learning-based recurrence prediction and risk stratification of lung adenocarcinoma from pathology whole-slide images.BMC cancer · 2026Article
- Development and Validation of a SHAP-Interpretable Machine Learning Model for Stroke Risk Prediction Using Circulating MicroRNA Biomarkers.Journal of molecular neuroscience : MN · 2026Article
- Explainable Artificial Intelligence in Mammography: A Systematic Review of Methods, Evaluation Practices, and Clinical Readiness.Diagnostics (Basel, Switzerland) · 2026Review
- Predictive modeling of axillary web syndrome in Chinese postoperative breast cancer patients using interpretable machine learning.Frontiers in oncology · 2026Article
- Habitat imaging based on DCE-MRI for differentiating luminal and non-luminal subtypes of breast cancer: a two-center study.Frontiers in oncology · 2026Article
- Prediction of germline BRCA mutation using clinicopathologic, MRI semantic, and radiomics features in high-risk breast cancer patients: a multicenter study.Frontiers in radiology · 2026Article
- Development and validation of a prognostic model for stage IV breast cancer based on primary tumor resection with machine learning methods: retrospective cohort study.Frontiers in endocrinology · 2026Article
- A multimodal deep learning radiomics nomogram integrating clinicopathological features for predicting pathological complete response after neoadjuvant therapy in triple-negative breast cancer: a multicenter retrospective study.Frontiers in oncology · 2026Article
- Risk Factors and Prognosis Analysis of Infiltrating Micropapillary Carcinoma of Breast: A Retrospective Study.Breast cancer (Dove Medical Press) · 2026Article
- Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In women with ductal carcinoma Methods: We retrospectively analyzed 140 DCIS patients from Harbin Medical University Cancer Hospital (2011-2020, followed up to 2025). Preoperative digital mammograms and clinicopathological data were collected, with mammographic features extracted using pyradiomics and supervised by a senior radiologist. Feature selection employed 10-fold cross-validated LASSO regression. The dataset was split into training (n=100) and validation (n=40) sets (10:4 ratio). Sixteen machine learning algorithms combining mammographic deep learning features and clinicopathological variables were developed and compared for predicting DCIS recurrence. Model performance was assessed using ROC, sensitivity, specificity, PPV, NPV, and SHAP values for interpretation. Results: The Gradient Boosting Machine (GBM) algorithm had the best predictive performance, with an AUC of 0.918 (95% CI 0.873-0.963) in the test set. SHAP values indicated that the mammographic signature (MS) was the most significant predictor, followed by Ki-67 index and histological grade. Patients not receiving radiotherapy had higher recurrence rates than those who did. Decision curve analysis validated the model's clinical utility across various risk thresholds. Conclusion: Our study developed an interpretable GBM model incorporating mammographic and clinical data to predict DCIS recurrence (AUC = 0.918). Key predictors were mammographic signature, Ki-67, and tumor grade, offering clinicians a practical tool for personalized postoperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.